Tagista 24mg #30

Tagista instruction for use

Reed more and buy Tagista on this page

Composition

1 tablet of Tagista drug includes 8; 16 or 24 mg beta-histidine dihydrochloride is the active ingredient.
Auxiliary Ingredients:
    ICC;
    callidone 25;
    potato starch;
    aerosil;
    citric acid;
    magnesium stearate;
    talc.

Form of issue

The drug is available in the form of tablets of 30, 50, 60 or 90 pieces in one package.

pharmachologic effect

Improving microcirculation.

Pharmacodynamics and pharmacokinetics

Betagistin, an active ingredient in Tagista's preparation, mainly affects the histamine receptors H1 and H3 of the vestibular nuclei of the central nervous system and inner ear. Manifesting a direct agonistic effect on H1, and not direct on the NZ vascular receptors of the inner ear improves the penetrating ability and microcirculation of the capillaries, thereby normalizing, in the labyrinth and cochlea of ​​the ear, the pressure of the endolymph. Also, betagistin affects the increase in blood flow in the basilar artery and, due to the inhibition of the N3 receptors in the nuclei of the vestibular nerve, shows a pronounced central effect. Normalizes the neuronal conductivity of the vestibular nuclei at the level of the stem portion of the brain.
When taking medication, the intensity and frequency of dizziness decrease, the sense of noise in the ears decreases, the hearing improves (with the previous decrease).
With internal administration, betahistine is rapidly absorbed and has a slight association with plasma proteins. After 3 hours, its maximum plasma concentration is reached.
T1 / 2 about 3 - 4 hours.
In the form of a metabolite, it is virtually completely excreted in the urine for 24 hours.

Indications for use Tagista

Indications Tagista include the following conditions:
    syndrome or Meniere's disease;
    vestibular dizziness, developed for various reasons (for the purpose of prevention and therapy);
    syndromes, which are accompanied by headaches and / or dizziness, hearing loss, noise in the ears, nausea and vomiting.

Contraindications

At this time, the only absolute contraindication to taking Tagista is hypersensitivity to the components of the tablet, including the active ingredient and auxiliary ingredients.
Also, there is no reliable information about the effectiveness of Tagista and its side effects on the patient's body during lactation and pregnancy, as well as at the age of 18, from which tablets of the drug are not prescribed during these periods.
The medicine with caution and under constant supervision is taken with peptic ulcer (including indications in the anamnesis), bronchial asthma, pheochromocytoma.

Side effects

Among the side effects of the drug most often observed: gastrointestinal disorders, headaches and allergic reactions in the form of urticaria, skin itch and / or rash. Also, there is evidence of the development of Quincke's edema.

Tagista tablets, instructions for use

Instructions for use Tagista recommends taking the medicine orally, while eating.
Tablets with a mass content of betahistine - 8 mg appoint three times a day for 1-2 tablets, 16 mg - three times a day for 1 / 2-1 tablet, 24 mg twice a day for 1 tablet.
As a rule, the improvement of the morbid condition is observed already at the beginning of the treatment. A strong therapeutic effect manifests itself at the end of the second week of therapy and can develop over the next few months. Duration of application Tagista is determined individually, but most often the course of therapy takes a long time.

Overdose

With Tagista overdose, nausea with vomiting followed, cramps are possible.
Standard symptomatic therapy is shown, including gastric lavage with further intake of activated charcoal.

Interaction

There is no information on cases of incompatibility or interaction with other medicinal products.

Storage conditions

In a place protected from children and light, at a temperature of no higher than 25 ° C.
Shelf life - 36 months.

special instructions

Betagistin does not show sedative effect, in connection with which, it can be assigned to drivers or other people whose profession requires the speed of psychomotor reactions.

Children

It is not used for therapy of patients under 18 years of age.

During pregnancy (and lactation)

It is not prescribed during periods of lactation and pregnancy.

Reviews about Tagista

Among doctors who use this drug, reviews about Tagista testify to the versatile effect of the drug on various pathogenetic factors of dizziness, which is the reason for its appointment in many disorders of the vestibular apparatus.
Efficacy Tagista, with minimal side effects, is assessed in 95% of cases, which allows recommending the drug to a wide range of patients.
The responses of people who for one reason or another have taken Tagista are diverse, from extremely positive to negative. In fairness, it should be noted that it is often possible to find evidence of self-prescribing beta-histidine drugs and the negative effects of taking them with dizziness. This may be due to the cause of dizziness, improper dosing, a small course of therapy and many other factors, so before any treatment, you should consult a doctor.